Tag: M.W:200-300

HPLC of Formula: 67929-86-6. The protonation of heteroatoms in aromatic heterocycles can be divided into two categories: lone pairs of electrons are in the aromatic ring conjugated system; and lone pairs of electrons do not participate. Compound: Methyl 5-methoxyindole-2-carboxylate, is researched, Molecular C11H11NO3, CAS is 67929-86-6, about Rapid synthesis of the indole-indolone scaffold via [3+2] annulation of arynes by methyl indole-2-carboxylates. Author is Rogness, Donald C.; Larock, Richard C..

The reaction of Me indole-2-carboxylates, e.g., I, and arynes afforded a very efficient, high yielding synthesis of a novel indole-indolone ring system, e.g., II, which tolerated considerable functionality, was broad in scope, and proceeded under mild reaction conditions.

Here is a brief introduction to this compound(67929-86-6)HPLC of Formula: 67929-86-6, if you want to know about other compounds related to this compound(67929-86-6), you can read my other articles.

Reference:
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem

Application In Synthesis of 3,5-Di(pyridin-2-yl)-4H-1,2,4-triazol-4-amine. So far, in addition to halogen atoms, other non-metallic atoms can become part of the aromatic heterocycle, and the target ring system is still aromatic. Compound: 3,5-Di(pyridin-2-yl)-4H-1,2,4-triazol-4-amine, is researched, Molecular C12H10N6, CAS is 1671-88-1, about Syntheses, Crystal Structures, and Fluorescence Properties of Cd(II), Ag(I) Complexes Based on 3,5-bis(pyridin-2-yl)-4-amino-1,2,4-triazole.

Two d10 complexes [Cd()I2(H2O)] (1) and [Ag2()2]·2(CF3SO3) (2), (abt = 4-amino-3,5-bis(pyridin-2-yl)-1,2,4-triazole) were obtained and characterized by IR, elemental anal., and x-ray diffraction single-crystal anal. Complex 1 is mononuclear and Cd(II) center is five coordinated, while complex 2 possesses a dinuclear structure with coordination number 4 for Ag(I) center. Solid-state fluorescence spectra of 1, 2, and abt were studied at room temperature

Here is a brief introduction to this compound(1671-88-1)Application In Synthesis of 3,5-Di(pyridin-2-yl)-4H-1,2,4-triazol-4-amine, if you want to know about other compounds related to this compound(1671-88-1), you can read my other articles.

Reference:
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem

The preparation of ester heterocycles mostly uses heteroatoms as nucleophilic sites, which are achieved by intramolecular substitution or addition reactions. Compound: Methyl 5-methoxyindole-2-carboxylate( cas:67929-86-6 ) is researched.Related Products of 67929-86-6.Di Giacomo, Barbara; Bedini, Annalida; Spadoni, Gilberto; Tarzia, Giorgio; Fraschini, Franco; Pannacci, Marilou; Lucini, Valeria published the article 《Synthesis and biological activity of new melatonin dimeric derivatives》 about this compound( cas:67929-86-6 ) in Bioorganic & Medicinal Chemistry. Keywords: melatonin dimeric derivative synthesis structure activity relationship receptor. Let’s learn more about this compound (cas:67929-86-6).

A new series of melatonin (MLT) dimers were obtained by linking together two melatonin units with a linear alkyl chain through the MLT acetamido group or through a C-2 carboxyalkyl function. The binding properties of these ligands were evaluated in in vivo experiments on cloned human MT1 and MT2 receptors expressed in NIH3T3 rat fibroblast cells. The class of 2-carboxyalkyl dimers was the most interesting one with compounds having good MT1/MT2 nanomolar affinity. The data obtained suggest that the spacer length is crucial for optimal interaction at both receptor subtypes as well as to determine functional activity of the resulting dimers.

Here is a brief introduction to this compound(67929-86-6)Related Products of 67929-86-6, if you want to know about other compounds related to this compound(67929-86-6), you can read my other articles.

Reference:
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem

The preparation of ester heterocycles mostly uses heteroatoms as nucleophilic sites, which are achieved by intramolecular substitution or addition reactions. Compound: Methyl 5-methoxyindole-2-carboxylate( cas:67929-86-6 ) is researched.Formula: C11H11NO3.Song, Jeong Uk; Jang, Jae Wan; Kim, Tae Hun; Park, Heuisul; Park, Wan Su; Jung, Sang-Hun; Kim, Geun Tae published the article 《Structure-based design and biological evaluation of novel 2-(indol-2-yl) thiazole derivatives as xanthine oxidase inhibitors》 about this compound( cas:67929-86-6 ) in Bioorganic & Medicinal Chemistry Letters. Keywords: structure indolyl thiazole derivative preparation xanthine oxidase antiinflammatory gout; 2-(Indol-2-yl)thiazole; Hyperuricemia; Molecular modeling; Structure–activity relationship; Xanthine oxidase inhibitors. Let’s learn more about this compound (cas:67929-86-6).

Inhibition of xanthine oxidase (XO) has obviously been a central concept for controlling hyperuricemia, which causes serious and painful inflammatory arthritis disease such as gout. We discovered a series of novel 2-(indol-2-yl)thiazole derivatives as XO inhibitors at the level of nanomolar activity. Structure-guided design using mol. modeling program (Accelrys Software program) provided an excellent basis for optimization of 2-(indol-2-yl)thiazole compounds Structure-activity relationship indicated that hydrophobic alkoxy group (isopropoxy, cyclopentoxy) at 5-position and hydrogen binding acceptor (NO2, CN) at 7-position of indole ring appear as critical functional groups. Among the compounds, 2-(7-nitro-5-isopropoxy-indol-2-yl)-4-methylthiazole-5-carboxylic acid (9m) exhibits the most potent XO inhibitory activity (IC50 value: 5.1 nM) and the excellent uric acid lowering activity in potassium oxonate induced hyperuricemic rat model.

Here is a brief introduction to this compound(67929-86-6)Formula: C11H11NO3, if you want to know about other compounds related to this compound(67929-86-6), you can read my other articles.

Reference:
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem

Most of the compounds have physiologically active properties, and their biological properties are often attributed to the heteroatoms contained in their molecules, and most of these heteroatoms also appear in cyclic structures. A Journal, Article, ACS Medicinal Chemistry Letters called Design and Evaluation of Bispidine-Based SARS-CoV-2 Main Protease Inhibitors, Author is Shcherbakov, Dmitriy; Baev, Dmitriy; Kalinin, Mikhail; Dalinger, Alexander; Chirkova, Varvara; Belenkaya, Svetlana; Khvostov, Aleksei; Krut’ko, Dmitry; Medved’ko, Aleksei; Volosnikova, Ekaterina; Sharlaeva, Elena; Shanshin, Daniil; Tolstikova, Tatyana; Yarovaya, Olga; Maksyutov, Rinat; Salakhutdinov, Nariman; Vatsadze, Sergey, which mentions a compound: 13599-22-9, SMILESS is OC(=O)C1=NN(C(=C1)C1=CC=CC=C1)C1=CC=CC=C1, Molecular C16H12N2O2, Reference of 1,5-Diphenyl-1H-pyrazole-3-carboxylic acid.

For the first time, derivatives of 3,7-diazabicyclo[3.3.1]nonane (bispidine) were proposed as potential inhibitors of the SARS-CoV-2 main viral protease (3-chymotrypsin-like, 3CLpro). Based on the created pharmacophore model of the active site of the protease, a group of compounds were modeled and tested for activity against 3CLpro. The 3CLpro activity was measured using the fluorogenic substrate Dabcyl-VNSTLQSGLRK(FAM)MA; the efficiency of the proposed approach was confirmed by comparison with literature data for ebselen and disulfiram. The results of the experiments performed with bispidine compounds showed that 14 compounds exhibited activity in the concentration range 1-10μM, and 3 samples exhibited submicromolar activity. The structure-activity relationship studies showed that the mols. containing a carbonyl group in the ninth position of the bicycle exhibited the maximum activity. Based on the exptl. and theor. results obtained, further directions for the development of this topic were proposed.

Here is a brief introduction to this compound(13599-22-9)Reference of 1,5-Diphenyl-1H-pyrazole-3-carboxylic acid, if you want to know about other compounds related to this compound(13599-22-9), you can read my other articles.

Reference:
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem

223671-15-6, 7-Bromoisoquinolin-1-ol is a isoquinoline compound, ?involved in a variety of chemical synthesis. Rlated chemical reaction is continuously updated

Preparation 63 1,4-Dichloro-7-isoquinolinecarbonyl chloride A solution of N-chlorosuccinimide (4.13 g, 31 mmol) in MeCN (50 mL) was added dropwise to a stirred solution of 7-bromo-1-(2H)-isoquinolone (6.6 g, 29.5 mmol) in MeCN (150 mL) which was heating under reflux. The mixture was heated under reflux for an additional 3 h and then cooled to room temperature. The resulting precipitate was collected by filtration, with MeCN rinsing, and then dried in vacuo to give 7-bromo-4-chloro-1(2H)-isoquinolone (6.72 g, 26.0 mmol) as a white solid. mp 241-243 C. 1H (DMSO-d6, 300 MHz) delta 7.5 (1H, s), 7.73 (1H, d), 7.8 (1H, dd), 8.3 (1H, s) ppm. LRMS 259 (MH+), 517 (M2H+). Anal. Found: C, 41.69; H, 1.90; N, 5.37. Calc for C9H5BrClNO: C, 41.80; H, 1.95; N, 5.42., 223671-15-6

As the paragraph descriping shows that 223671-15-6 is playing an increasingly important role.

Reference：
Patent; PFIZER INC.; Pfizer Limited; EP1077945; (2003); B1;,
Isoquinoline – Wikipedia
Isoquinoline | C9H7N – PubChem

With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.63927-22-0,8-Bromoisoquinoline,as a common compound, the synthetic route is as follows.

63927-22-0, To a 100 mL round-bottomed flask equipped with condenser and N2 inlet were added 2.46 g (11.8 mmol) 8-bromoisoquinoline, 1.68 mL (14.1 mmol) benzyl bromide, and 10 mL ethanol. The solution was heated at reflux for 6 hr, cooled, and evaporated. The oil was dissolved in 50 mL methanol, and 1.73 g (27.6 mmol) sodium cyanoborohydride was added. The solution was stirred at room temperature for 5 days, then diluted with water and extracted with three portions of ethyl acetate. The organic layer was washed with brine, dried over sodium sulfate, and evaporated. The residue was chromatographed on silica gel using hexane/ethyl acetate to afford 1.98 g (59percent) of an oil. 1H-NMR (delta, CDCl3): 2.68 (m, 2H), 2.88 (m, 2H), 3.68 (m, 2H), 3.75 (m, 2H), 7.0-7.1 (m, 2H), 7.2-7.4 (m, 6H).

63927-22-0 8-Bromoisoquinoline 9859134, aisoquinoline compound, is more and more widely used in various fields.

Reference：
Patent; Pfizer Inc; US2004/254193; (2004); A1;,
Isoquinoline – Wikipedia
Isoquinoline | C9H7N – PubChem

With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.1242157-15-8,6-Bromo-8-fluoro-3,4-dihydroisoquinolin-1(2H)-one,as a common compound, the synthetic route is as follows.

1242157-15-8, To a stirred solution of CD3OD (CAS 811-98-3; 3.1 mL, 76.2 mmol, 6 eq.) in THF (31 mL) at 0 C is added portionwise NaH (60% dipersion in mineral oil, 366 mg, 15.24 mmol, 1.2 eq.). The reaction mixture is stirred at 0 C for 20 min and 6-bromo-8-fluoro-3,4-dihydro-2H-isoquinolin-l-one (CAS 1242157-15-8, 3.1 g, 12.7 mmol, 1 eq.) is added in one portion. The reaction is stirred at RT for 1.5 h and NaH (60% dipersion in mineral oil, 60 mg, 2.5 mmol, 0.2 eq.) is added. The reaction mixture is stirred at RT for 18 h. The reaction mixture is quenched with a sat. NH4CI solution. THF is evaporated and water (31 mL) is added to the suspension.The suspension is stirred at RT for 1 h and then filtered. The solid is rinsed with water and dried under vacuum to afford the expected product.

The synthetic route of 1242157-15-8 has been constantly updated, and we look forward to future research findings.

Reference：
Patent; GALAPAGOS NV; DESROY, Nicolas; JONCOUR, Agnes, Marie; PEIXOTO, Christophe; TEMAL-LAIB, Taoues; TIRERA, Amynata; BUCHER, Denis; AMANTINI, David; DE VOS, Steve, Irma, Joel; BRYS, Reginald, Christophe, Xavier; (396 pag.)WO2019/238424; (2019); A1;,
Isoquinoline – Wikipedia
Isoquinoline | C9H7N – PubChem

104704-40-7, 4-Bromo-1-methylisoquinoline is a isoquinoline compound, ?involved in a variety of chemical synthesis. Rlated chemical reaction is continuously updated

Example No. 130: Preparation of Compound No. 164[0418] A solution of 2, 8-dimethyl-2, 3, 4, 5-tetrahydro- lH-pyrido[4,3-b]indole (310 mg, 1.55 mmol), K3P04 (0.985 g, 4.65 mmol), Cul (29.4 mg, 0.15 mmol), L-proline (35.6 mg, 0.31 mmol) and 4-bromo-l-methylisoquinoline (0.520 g, 2.35 mmol) in dry DMF (3 mL) was stirred at RT for 10 min and then at 150 C for 16h. Water (50 mL) was added to the reaction mixture and then extracted with EtOAc (150 mL). The organic layer was washed with water (6×30 mL), dried over anhydrous sodium sulfate and evaporated to afford crude material, which was purified by reverse phase HPLC to yield 2,8-dimethyl-5-(l-methylisoquinolin-4-yl)-2,3,4,5-tetrahydro- lH-pyrido[4,3-b]indole as the TFA salt. 1H NMR (CD3OD, TFA salt) delta (ppm): 8.6-8.74 (m,2H), 8.0 (m, 2H), 7.41 (s, IH), 7.38 (bs, IH), 7.0 (d, IH), 6.8 (bs, IH), 4.8 (bs, IH), 4.5 (bs, IH), 3.8 (bs, IH), 3.6 (bs, IH), 3.3 (s, 3H), 3.18 (s, 3H), 3.0 (bs, IH), 2.82 (bs, IH), 2.41 (s, 3H)., 104704-40-7

As the paragraph descriping shows that 104704-40-7 is playing an increasingly important role.

Reference：
Patent; MEDIVATION TECHNOLOGIES, INC.; PROTTER, Andrew, Asher; CHAKRAVARTY, Sarvajit; WO2012/112962; (2012); A1;,
Isoquinoline – Wikipedia
Isoquinoline | C9H7N – PubChem

223671-15-6, 7-Bromoisoquinolin-1-ol is a isoquinoline compound, ?involved in a variety of chemical synthesis. Rlated chemical reaction is continuously updated

A solution of 7-bromo-1-hydroxyisoquinoline (2. 00g, 8. [93MMOL)] in MeOH (50mL) was treated with triethylamine (2.6mL, 18.7mmol), and [1,] [1′-] Bis (diphenylphosphino) ferrocene (0.15g, 0. [27MMOL)] in a sealed reactor and heated to [100XB0;C] for 20 hours. The mixture was cooled to room temperature, the tan slurry filtered, the solid washed with MeOH, then ethyl acetate, and dried. This afforded 1.55g of the product as a gray solid (85.4% yield). [H-NMR] [(DMSO-D6)] ; 11.48 (s, [1H),] 8.72 (s, 1H), 8.14-8. 12 (d, 1H), 7.74-7. 72 (d, 1H), 7.31-7. 28 (t, [1H),] 3.86 (s, [3H)] MS: [M+ +1= 204.] 1 Da, 223671-15-6

The synthetic route of 223671-15-6 has been constantly updated, and we look forward to future research findings.

Reference：
Patent; WARNER-LAMBERT COMPANY LLC; WO2004/14379; (2004); A1;,
Isoquinoline – Wikipedia
Isoquinoline | C9H7N – PubChem